JP2023516648A5 - - Google Patents
Info
- Publication number
- JP2023516648A5 JP2023516648A5 JP2022552405A JP2022552405A JP2023516648A5 JP 2023516648 A5 JP2023516648 A5 JP 2023516648A5 JP 2022552405 A JP2022552405 A JP 2022552405A JP 2022552405 A JP2022552405 A JP 2022552405A JP 2023516648 A5 JP2023516648 A5 JP 2023516648A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- spp
- compound
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062985274P | 2020-03-04 | 2020-03-04 | |
| US62/985,274 | 2020-03-04 | ||
| PCT/US2021/020471 WO2021178406A1 (en) | 2020-03-04 | 2021-03-02 | Use of compounds in the treatment of fungal infections |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023516648A JP2023516648A (ja) | 2023-04-20 |
| JP2023516648A5 true JP2023516648A5 (https=) | 2024-04-08 |
Family
ID=77612811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022552405A Pending JP2023516648A (ja) | 2020-03-04 | 2021-03-02 | 真菌感染症の処置における化合物の使用 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US12521406B2 (https=) |
| EP (1) | EP4114405A4 (https=) |
| JP (1) | JP2023516648A (https=) |
| KR (1) | KR20220148881A (https=) |
| CN (1) | CN115515599A (https=) |
| AU (1) | AU2021230529B2 (https=) |
| BR (1) | BR112022017653A2 (https=) |
| CA (1) | CA3174065A1 (https=) |
| IL (1) | IL296093A (https=) |
| MX (1) | MX2022010804A (https=) |
| WO (1) | WO2021178406A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3187268A1 (en) * | 2020-06-17 | 2021-12-23 | Amplyx Pharmaceuticals, Inc. | Compounds and methods for treating fungal infections |
| CN116687929B (zh) * | 2023-06-16 | 2026-04-28 | 山东省妇幼保健院 | 血根碱在制备防治临床罕见真菌相关感染性疾病药物中的应用 |
| WO2026020112A1 (en) * | 2024-07-19 | 2026-01-22 | Sun Pharmaceutical Industries, Inc. | Oral formulations of deuruxolitinib |
| CN119915948B (zh) * | 2025-04-02 | 2025-07-08 | 天津辰欣药物研究有限公司 | 一种小分子真菌肌醇酰基转移酶1抑制剂原料药中致突变杂质的分析方法 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8513287B2 (en) | 2007-12-27 | 2013-08-20 | Eisai R&D Management Co., Ltd. | Heterocyclic ring and phosphonoxymethyl group substituted pyridine derivatives and antifungal agent containing same |
| EP2345641A1 (en) | 2009-12-29 | 2011-07-20 | Polichem S.A. | New secondary 8-hydroxyquinoline-7-carboxamide derivatives |
| EP2636409A1 (en) * | 2010-11-05 | 2013-09-11 | Eisai R&D Management Co., Ltd. | Combined pharmaceutical composition as antifungal agent |
| IL275121B2 (en) * | 2017-12-07 | 2025-11-01 | Amplyx Pharmaceuticals Inc | Heterocycle substituted pyridine derivative antifungal agents |
| WO2020047510A1 (en) | 2018-08-31 | 2020-03-05 | Amplyx Pharmaceuticals, Inc. | Compounds and methods for treating fungal infections |
| CA3187268A1 (en) | 2020-06-17 | 2021-12-23 | Amplyx Pharmaceuticals, Inc. | Compounds and methods for treating fungal infections |
-
2021
- 2021-03-02 MX MX2022010804A patent/MX2022010804A/es unknown
- 2021-03-02 WO PCT/US2021/020471 patent/WO2021178406A1/en not_active Ceased
- 2021-03-02 KR KR1020227034025A patent/KR20220148881A/ko not_active Ceased
- 2021-03-02 BR BR112022017653A patent/BR112022017653A2/pt unknown
- 2021-03-02 CA CA3174065A patent/CA3174065A1/en active Pending
- 2021-03-02 AU AU2021230529A patent/AU2021230529B2/en active Active
- 2021-03-02 IL IL296093A patent/IL296093A/en unknown
- 2021-03-02 US US17/908,079 patent/US12521406B2/en active Active
- 2021-03-02 JP JP2022552405A patent/JP2023516648A/ja active Pending
- 2021-03-02 EP EP21765099.3A patent/EP4114405A4/en active Pending
- 2021-03-02 CN CN202180033043.8A patent/CN115515599A/zh active Pending
-
2025
- 2025-12-15 US US19/420,144 patent/US20260102419A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023516648A5 (https=) | ||
| US12521406B2 (en) | Use of compounds in the treatment of fungal infections | |
| KR100380871B1 (ko) | 항진균성 약제학적 조성물 | |
| US20230364067A1 (en) | Antifungal agents with enhanced activity in acidic ph | |
| JP2018513869A5 (https=) | ||
| Harari | Current strategies in the treatment of invasive Aspergillus infections in immunocompromised patients | |
| Fica et al. | Unsuccessful treatment with voriconazole of a brain abscess due to Cladophialophora bantiana | |
| Van Cutsem | In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents. | |
| NZ792042B2 (en) | Use of compounds in the treatment of fungal infections | |
| JP2023530936A5 (https=) | ||
| AU2021293911B2 (en) | Compounds and methods for treating fungal infections | |
| JP7562542B2 (ja) | 真菌性骨－関節感染症を治療するためのトリテルペノイド系抗真菌薬 | |
| US20250302821A1 (en) | Synergistic antifungal composition and method | |
| US20220047606A1 (en) | Treatment method with iap inhibitor | |
| Barza | Editorial response: Treatment options for candidal Endophthalmitis | |
| EA047126B1 (ru) | Противогрибковое средство для лечения или профилактики инфекции вульвовагинального кандидоза | |
| HK40044248A (en) | Treatment method with iap inhibitor | |
| Lee et al. | A Case of Intravitreal Voriconazole for the Treatment of Drug-resistant Penicillium Endophthalmitis | |
| HK40030410A (en) | Antifungal agents with enhanced activity in acidic ph | |
| Pappas | Antifungal Spectrum |